Design of Aminopeptidase N Inhibitors as Anti-cancer Agents

被引:87
|
作者
Amin, Sk Abdul [1 ]
Adhikari, Nilanjan [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Div Med & Pharmaceut Chem, Nat Sci Lab, POB 17020, Kolkata 700032, W Bengal, India
关键词
HEPATOCELLULAR-CARCINOMA CELLS; STREPTOMYCES-AZUREUS MH663-2F6; LEUCINE UREIDO DERIVATIVES; 1ST HIGHLY POTENT; MATRIX-METALLOPROTEINASE; CLINICAL-SIGNIFICANCE; SELECTIVE INHIBITORS; ACID-DERIVATIVES; PYRROLIDINE DERIVATIVES; BIOLOGICAL EVALUATION;
D O I
10.1021/acs.jmedchem.7b00782
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aminopeptidase N (APN) is an important metalloenzyme. It regulates multivariate cellular functions by different mechanisms such as enzymatic cleavage of peptides. This may play a role in endocytosis and regulate signal transduction. APN, a member of the MI zinc metallopeptidase family, plays crucial roles in a variety of functions such as migration and invasion, and angiogenesis and metastasis of tumor cells. Therefore, APN inhibitors may be useful for the treatment of cancer. In this Perspective, structure activity relationships of APN inhibitors are discussed to get an idea of possible lead candidates. APN inhibitors should possess an aryl hydrophobic function along with a zinc binding group attached to the hydrophobic group(s) to achieve high potency. This and other design aspects of APN inhibitors are discussed in this Perspective.
引用
收藏
页码:6468 / 6490
页数:23
相关论文
共 50 条
  • [21] Design, synthesis and evaluation of novel, selective carbonic anhydrase IX inhibitors as anti-cancer agents
    Wang, R.
    Glassbrook, L.
    Bryce, R.
    Stratford, I.
    Supuran, C.
    Jaffar, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 53 - 54
  • [22] Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents
    You, Hyun
    Youn, Hyung-Seop
    Im, Isak
    Bae, Man-Ho
    Lee, Sang-Kook
    Ko, Hyojin
    Eom, Soo Hyun
    Kim, Yong-Chul
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (04) : 1153 - 1164
  • [23] Anti-cancer agents .1. N,N,N',N'-Tetraacetylhexamethylenediamine
    Zhang, SW
    Liu, Q
    Wei, YG
    Shao, MC
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1996, 52 : 1238 - 1239
  • [24] Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer Agents
    Martino, Elena
    Thakur, Shruti
    Kumar, Arun
    Yadav, Ashok Kumar
    Boschi, Donatella
    Kumar, Deepak
    Lolli, Marco
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (22) : 1983 - 2007
  • [25] Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
    Jiahuai Tan
    Shundong Cang
    Yuehua Ma
    Richard L Petrillo
    Delong Liu
    Journal of Hematology & Oncology, 3
  • [26] Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents
    Dhuguru, Jyothi
    Ghoneim, Ola A.
    MOLECULES, 2022, 27 (07):
  • [27] Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents
    Gonelli, A.
    Mischiati, C.
    Guerrini, R.
    Voltan, R.
    Salvadori, S.
    Zauli, G.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (04) : 498 - 509
  • [28] Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents
    Zhang, Li
    Lei, Jine
    Shan, Yuanyuan
    Yang, Hao
    Song, Maxiaowei
    Ma, Ying
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (14) : 1999 - 2013
  • [29] Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
    Tan, Jiahuai
    Cang, Shundong
    Ma, Yuehua
    Petrillo, Richard L.
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
  • [30] Design of novel anti-cancer agents targeting COX-2 inhibitors based on computational studies
    Er-rajy, Mohammed
    El Fadili, Mohamed
    Mujwar, Somdutt
    Imtara, Hamada
    Al Kamaly, Omkulthom
    Alshawwa, Samar Zuhair
    Nasr, Fahd A.
    Zarougui, Sara
    Elhallaoui, Menana
    ARABIAN JOURNAL OF CHEMISTRY, 2023, 16 (10)